Viatris Income Taxes 2010-2024 | VTRS

Viatris annual/quarterly income taxes history and growth rate from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Viatris income taxes for the quarter ending September 30, 2024 were $-0.004B, a 106.09% decline year-over-year.
  • Viatris income taxes for the twelve months ending September 30, 2024 were $-0.068B, a 109.84% decline year-over-year.
  • Viatris annual income taxes for 2023 were $0.148B, a 79.83% decline from 2022.
  • Viatris annual income taxes for 2022 were $0.735B, a 21.48% increase from 2021.
  • Viatris annual income taxes for 2021 were $0.605B, a 1278.75% decline from 2020.
Viatris Annual Income Taxes
(Millions of US $)
2023 $148
2022 $735
2021 $605
2020 $-51
2019 $138
2018 $-54
2017 $207
2016 $-358
2015 $68
2014 $41
2013 $121
2012 $161
2011 $116
2010 $10
2009 $-21
Viatris Quarterly Income Taxes
(Millions of US $)
2024-09-30 $-4
2024-06-30 $-65
2024-03-31 $91
2023-12-31 $-89
2023-09-30 $71
2023-06-30 $69
2023-03-31 $98
2022-12-31 $458
2022-09-30 $73
2022-06-30 $75
2022-03-31 $128
2021-12-31 $60
2021-09-30 $-112
2021-06-30 $60
2021-03-31 $596
2020-12-31 $-98
2020-09-30 $56
2020-06-30 $-19
2020-03-31 $10
2019-12-31 $115
2019-09-30 $-4
2019-06-30 $116
2019-03-31 $-90
2018-12-31 $26
2018-09-30 $16
2018-06-30 $-19
2018-03-31 $-77
2017-12-31 $83
2017-09-30 $91
2017-06-30 $28
2017-03-31 $5
2016-12-31 $-193
2016-09-30 $-206
2016-06-30 $35
2016-03-31 $5
2015-12-31 $24
2015-09-30 $27
2015-06-30 $13
2015-03-31 $5
2014-12-31 $82
2014-09-30 $-87
2014-06-30 $11
2014-03-31 $35
2013-12-31 $12
2013-09-30 $36
2013-06-30 $41
2013-03-31 $32
2012-12-31 $29
2012-09-30 $53
2012-06-30 $51
2012-03-31 $29
2011-12-31 $-1
2011-09-30 $35
2011-06-30 $56
2011-03-31 $26
2010-12-31 $-23
2010-09-30 $-12
2010-06-30 $14
2010-03-31 $31
2009-12-31 $-73
2009-09-30 $-11
2009-06-30 $26
2009-03-31 $37
Sector Industry Market Cap Revenue
Medical Medical Services $15.624B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00